Attempting to Discontinue Some patients want to try stopping medication after achieving goals
Designed for larger areas like the stomach, thighs, flanks (love handles), or back Beth H Honestly felt so comfortable the whole time
This work was supported by the Wilmot Cancer Institute Predoctoral Fellowship (G.A.), Wilmot Cancer Institute Pilot Funding (I.S.H.), the American Association for Cancer Research and Breast Cancer Research Foundation (20-20-26-HARR) (I.S.H.), Breast Cancer Coalition of Rochester (I.S.H.), a Sir Henry Wellcome Postdoctoral Fellowship (M.E.K.), and a FNR-CORE grant C21/BM/15796788 (D.B.), and NIH grants R01CA269813 (I.S.H.), R37CA230042 (G.M.D), R24AA022057 (V.V.), R01AA028859 (Y.C.), AI150698 (J.M.), K01CA240533-01A1 (C.L.C.), and R01AR078000 (R.T.D.)
Patients taking the highest dose of Zepbound (15mg) in phase 3 clinical trials lost 48 pounds on average at 72 weeks, representing a ~20% body weight reduction
Validit a confezionamento integro: 36 mesi